Psychiatrists welcome new MBS inclusion for major depressive disorders

The Royal Australian and New Zealand College of Psychiatrists (RANZCP) has welcomed the Government’s announcement of $288.5 million to list Repetitive Transcranial Magnetic Stimulation (rTMS) therapy for patients with medication resistant major depressive disorder. RANZCP President, Associate Professor John Allan, supported the announcement that patients will now have access supported by Medicare to a wider…

Read More

Reflection on TMS and migraines by Dr Michael Dunne

Repetitive Transcranial Magnetic Stimulation (rTMS) is a growing field which has a strong evidence base as an alternative or additive to medications in depression[1]. Generalised anxiety disorder, obsessive compulsive disorder[2] and post-traumatic stress disorder[3] also display positive outcomes in an expanding set of research data. rTMS has also been used in management of physical symptoms.…

Read More

The evolving role of TMS therapy in pain management

If you look up “TMS” and “pain management”, you may run into articles on “Tension myositis syndrome”, a diagnosis of back pain raised by John E. Sarno in the 90s. It is completely unrelated and conceals some of the latest research on transcranial magnetic stimulation on that tyranny, the Web. TMS is famous for “pain…

Read More

TMS: an answer for those with both depression and autism?

Moreover, depression in those with autism… “tends to be more severe …” “Is more likely to be refractory to treatment” Can resist the effects of antidepressants, and “antidepressants can make […] autism symptoms worse” These are the revelations of McLeod Gwynette, Director of the General Psychiatry Clinic at the Medical University of South Carolina. As…

Read More